Johannes G. C. P. Schikan
Fundador en PHARVARIS N.V. .
Fortuna: 12 M $ al 30/04/2024
Origen de la red de primer grado Johannes G. C. P. Schikan.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.
220
| Non-Profit Organization | Miscellaneous Commercial Services | 220 |
Public Company | Pharmaceuticals: Major | 56 | |
Public Company | Pharmaceuticals: Major | 25 | |
Public Company | Pharmaceuticals: Major | 22 | |
Extinct | Pharmaceuticals: Major | 20 | |
Extinct | Biotechnology | 14 | |
Public Company | Pharmaceuticals: Major | 14 | |
Subsidiary | Pharmaceuticals: Major | 12 | |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands.
10
| Holding Company | Biotechnology | 10 |
Complix NV
Complix NV Pharmaceuticals: MajorHealth Technology Complix NVengages in the development of biopharmaceutical company developing Alphabodies, a pipeline of transformative protein therapeutics. The Company is currently focusing its internal research and development activities on oncology and autoimmune diseases. Its therapeutic Alphabodies focuses on the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis and multiple sclerosis, and infectious diseases, and viral diseases such as influenza, HIV, and RSV. The company was founded by Mark Vaeck and Ignace Lasters in 2008 and is headquartered in Diepenbeek, Belgium.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Microbiotica Ltd.
Microbiotica Ltd. BiotechnologyHealth Technology Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom.
8
| Holding Company | Biotechnology | 8 |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland.
8
| Subsidiary | Biotechnology | 8 |
Therachon Holding GmbH
Therachon Holding GmbH BiotechnologyHealth Technology Therachon Holding GmbH engages in the acquisition, management, financing, and disposal of participating interests in firms. It also acquires, holds, and disposes intellectual property rights. The company was founded on December 22, 2015 and is headquartered in Basel, Switzerland.
3
| Extinct | Biotechnology | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Johannes G. C. P. Schikan a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | General Counsel Corporate Officer/Principal Sales & Marketing | |
GILEAD SCIENCES, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Sales & Marketing | |
IMMUNOGEN, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer Chief Executive Officer | |
SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
ATRECA, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Director of Finance/CFO | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Graduate Degree Graduate Degree Graduate Degree | |
Stanford University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
UCB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | President President Corporate Officer/Principal | |
University of Lund | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
The Biotechnology Institute
The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
New England Healthcare Institute
New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
University of Gothenburg | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
RELYPSA INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member Chairman | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Centogene AG
Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
LYSOGENE | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Therachon SAS
Therachon SAS BiotechnologyHealth Technology TherAchon SAS provides biotechnology services. It specializes in research and development for achondroplasia and its associated complications. The company was founded by Elvire Gouze in 2014 and is headquartered in Biot, France. | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Chairman Director/Board Member | |
DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
CODA Biotherapeutics, Inc.
CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
INIM Pharma AB
INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member | |
PASSAGE BIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member Founder | |
CENTOGENE N.V. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
ALKERMES PLC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 31 |
Suecia | 6 |
Suiza | 4 |
Francia | 4 |
Dinamarca | 3 |
Sectorial
Health Technology | 37 |
Consumer Services | 8 |
Commercial Services | 5 |
Finance | 2 |
Health Services | 2 |
Operativa
Director/Board Member | 748 |
Corporate Officer/Principal | 256 |
Independent Dir/Board Member | 208 |
Chairman | 164 |
Chief Executive Officer | 153 |
Las relaciones más conectadas
Insiders | |
---|---|
Jean-Francois Formela | 47 |
David Mott | 45 |
Stephen P. Squinto | 40 |
Thomas Woiwode | 39 |
John Maraganore | 38 |
Flemming Ørnskov | 34 |
Martijn Kleijwegt | 33 |
Jacob Uno Stanley Gunterberg | 33 |
Ted Love | 31 |
N. Coles | 30 |
Rémi Droller | 29 |
Steven Holtzman | 28 |
David Pyott | 27 |
David Stack | 27 |
James Sapirstein | 26 |
- Bolsa de valores
- Insiders
- Johannes G. C. P. Schikan
- Conexiones Empresas